Acute vertebrobasilar occlusion: Current treatment strategies

Neurological Research

Volumn 27, Issue SUPPL. 1, 2005, Pages

  Eckert, Bernd ^a  

^a ASKLEPIOS KLINIK ALTONA   (Germany)

Author keywords

Abciximab; Fibrinolysis; Ischemic stroke; Stenting; Vasilar artery

Indexed keywords

ABCIXIMAB; ALTEPLASE; FIBRINOGEN RECEPTOR ANTAGONIST;

BLEEDING; EMBOLECTOMY; EMBOLISM; FIBRINOLYSIS; HUMAN; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; REVIEW; RHEOLYTIC THROMBECTOMY; STENT; THROMBOSIS; VERTEBRAL ARTERY STENOSIS;

ANGIOPLASTY, BALLOON; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PLATELET AGGREGATION INHIBITORS; STENTS; VERTEBROBASILAR INSUFFICIENCY;

EID: 27144550152     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/016164105X25324     Document Type: Review

References (53)

1. Kubik CS, Adams RD. Occlusion of the basilar artery-a clinical and pathological study. Brain 1946; 69: 73-121
2. Labauge R, Pages M, Marty-Double C, et al. Occlusion du tronc basilaire. Rev Neurol (Paris) 1981; 137: 545-571
3. Hacke W, Zeumer H, Ferbert A, et al. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke 1988; 19: 1216-1222
4. Zeumer H, Hacke W, Kolmann HL, et al. Lokale fibrinolysetherapie bei basilaristhrombose. Deutsch Med Wochenschr 1982; 107: 728-731
5. Zeumer H, Hacke WREB. Local intra-arterial thrombolysis in vertebrobasilar thromboembolic disease. Am J Neurol Res 1983; 4: 401-404
6. Levy EI, Firlik AD, Wisniewski S, et al. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: a meta-analytical approach. Neurosurgery 1999; 45: 539-545
7. Eckert B, Kucinski T, Pfeiffer G, et al. Endovascular therapy of acute vertebrobasilar occlusion: early treatment onset as the most important factor. Cerebrovasc Dis 2002; 14: 42-50
8. Cross D, Moran C, Akins P, et al. Relationship between clot location and outcome after basilar artery thrombolysis. Am J Neurol Res 1997; 18: 1221-1228
9. Caplan LR. Occlusion of the vertebral or basilar artery. Follow up analysis of some patients with benign outcome. Stroke 1979; 10: 277-282
10. Brandt T, Pessin M, Kwan A, et al. Survival with basilar occlusion. Cerebrovasc Dis 1995; 5: 182-187
11. Brandt T, von Kummer R, Muller Kuppers M, et al. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke 1996; 27: 875-881
12. Archer CR, Horenstein S. Basilar artery occlusion. Clinical and radiological correlation. Stroke 1977; 8: 383-390
13. Castaigne P, Lhermitte F, Gautier JC, et al. Arterial occlusions in the vertebrobasilar system. A study of 44 patients with postmortem data. Brain 1973; 96: 133-154
14. Fisher CM, Gore I, Okabe N, et al. Atherosclerosis of the carotid and vertebral arteries, extracranial and intracranial. J Neuropath exp Neurol 1965; 24: 455-476
15. Caplan, L, Pessin MS, Adelman LS, et al. Dissection of the intracranial vertebral artery. Neurology 1988; 38: 868-877
16. Ross GJ, Ferraro F, DeRiggi L, et al. Spontaneous healing of basilar artery dissection: MR findings. J Comput Assist Tomogr 1994; 18: 292-294
17. Van den Kleft E, Kunnen J, Truyen L, et al. Postpartum dissecting aneurysm of the basilar artery. Stroke 1992; 23: 114-116
18. Masson C, Krespy Y, Masson M, et al. Magnetic resonance imaging in basilar artery dissection. Stroke 1993; 24: 1264-1266
19. von Kummer R, Forsting M, Sartor K, et al. Intravenous recombinant tissue plasminogen activator in acute ischemic stroke. In: Hacke W ed., Thrombolytic Therapy in Acute Ischemic Stroke. Heidelberg: Springer, 1991: pp. 161-167
20. Hennerici M, Hacke W, Kv HCZW. Intravenous tissue plasminogen activator for the treatment of acute thrombembolic ischemia. Cerebrovasc Dis 1991; 1(Suppl 1): 124-128
21. Huemer M, Niederwieser V, Ladurner G. Thrombolytic treatment for acute occlusion of the basilar artery. J Neurol Neurosurg Psychiat 1995; 58: 227-228
22. Tissue plasminogen activator for acute ischemic stroke. The national institute of neurological disorders and stroke rt-pa stroke study group. N Engt J Med 1995; 333: 1581-1587
23. Grond M, Rudolf J, Schmulling S, et al. Early intravenous thrombolysis with recombinant tissue-type plasminogen activator in vertebrobasilar ischemic stroke see comments. Arch Neurol 1998; 55: 466-469
24. Lindsberg PJ, Soinne L, Tatlisumak T, et al. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. J Am Med Ass 2004; 292: 1862-1866
25. Becker K, Monsein L, Ulatowski J, et al. Intra-arterial thrombolysis in vertebrobasilar occlusion. AJNR. 1996;17:255-262
26. Egan R, Clark W, Lutsep H, et al. Efficacy of intra-arterial thrombolysis of basilar artery stroke. J Stroke Cerebrovasc Dis 1999; 8: 22-27
27. Nakayama T, Tanaka K, Kaneko M, et al. Thrombolysis and angioplasty for acute occlusion of intracranial vertebrobasilar arteries. Report of three cases. J Neurosurg 1998; 88: 919-922
28. Bellon RJ, Putman CM, Budzik RF, et al. Rheolytic thrombectomy of the occluded internal carotid artery in the setting of acute ischemic stroke. Am J Neurol Res Am J Neuroradiol 2001; 22: 526-530
29. Pierre Gobin Y, Starkman S, Duckwiler GR, et al. Merci 1: a phase 1 study of mechanical embolus removal in cerebral ischemia. Stroke 2004; 35: 2848-2854
30. Freitag HJ, Becker VU, Thie A, et al. Lys-plasminogen as an adjunct to local intra-arterial fibrinolysis for carotid territory stroke: laboratory and clinical findings. Neuroradiology 1996; 38: 181-185
31. Antman EM, Giugliano RP, Gibson CM, et al. Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (timi) 14 trial. The timi 14 investigators. Circulation 1999; 99: 2720-2732
32. GUSTO V Investigators. Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein iib/iiia inhibition: the gusto v randomised trial. Lancet 2001; 357: 1905-1914
33. Choudri TF, Hoh BL, Zerwes H-G, et al. Reduced microvascular thrombosis and improved outcome in acute murine stroke by inhibiting gp iib/iiia receptor-mediated platelet aggregation. J Clin Invest 1998; 102: 1301-1310
34. Abumiya T, Fitridge R, Mazur C, et al. Integrin alpha(iib)beta(3) inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia. Stroke 2000; 31: 1402-1409; discussion 1409-1410
35. Zhang L, Zhang ZG, Zhang R, et al. Adjuvant treatment with a glycoprotein iib/iiia receptor inhibitor increases the therapeutic window for low-dose tissue plasminogen activator administration in a rat model of embolic stroke. Circulation 2003; 107: 2837-2843
36. Burgin WS, Alexandrov AV. Deterioration following improvement with tpa therapy: carotid thrombosis and reocclusion. Neurology 2001; 56: 568-570
37. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology 2002; 59: 862-867
38. Qureshi AI, Siddiqui AM, Kim SH, et al. Reocclusion of recanalized arteries during intra-arterial thrombolysis for acute ischemic stroke. Am J Neurol Res Am J Neuroradiol 2004; 25: 322-328
39. Becker R. Dynamics of coronary thrombolysis and reocclusion. Clin Cardiol 1997; 20: III2-5
40. Moser M, Nordt T, Peter K, et al. Platelet function during and after thrombolytic therapy for acute myocardial infarction with reteplase, alteplase, or streptokinase. Circulation 1999; 100: 1858-1864
41. Reverter JC, Beguin S, Kessels H, et al. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7e3 antibody. Potential implications for the effect of c7e3 fab treatment on acute thrombosis and 'clinical restenosis'. J Clin Invest 1996; 98: 863-874
42. Zhu Y, Carmeliet P, Fay WP. Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance. Circulation 1999; 99: 3050-3055
43. Collet JP, Montalescot G, Lesty C, et al. Disaggregation of in vitro preformed platelet-rich clots by abciximab increases fibrin exposure and promotes fibrinolysis. Arterioscler Thromb Vasc Biol 2001; 21: 142-148
44. Wallace RC, Furlan AJ, Moliterno DJ, et al. Basilar artery rethrombosis: Successful treatment with platelet glycoprotein iib/ iiia receptor inhibitor. Am J Neurol Res Am J Neuroradiol 1997; 18: 1257-1260
45. Eckert B, Koch C, Thomalla G, et al. Acute basilar artery occlusion treated with combined intravenous abciximab and intra-arterial tissue plasminogen activator: report of 3 cases. Stroke 2002; 33: 1424-1427
46. Lee KY, Heo JH, Lee SI, et al. Rescue treatment with abciximab in acute ischemic stroke. Neurology 2001; 56: 1585-1587
47. Mounayer C, Piotin M, Baldi S, et al. Intra-arterial administration of abciximab for thromboembolic events occurring during aneurysm coil placement. Am J Neurol Res Am J Neuroradiol 2003; 24: 2039-2043
48. Junghans U, Seitz RJ, Wittsack HJ, et al. Treatment of acute basilar artery thrombosis with a combination of systemic alteplase and tirofiban, a nonpeptide platelet glycoprotein iib/iiia inhibitor. Radiology 2001; 221: 795-801
49. Straub S, Junghans U, Jovanovic V, et al. Systemic thrombolysis with recombinant tissue plasminogen activator and tirofiban in acute middle cerebral artery occlusion. Stroke 2004; 35: 705-709
50. Eckert B, Koch C, Thomalla G, et al. Aggressive therapy with i.v. Abciximab and i.a. rt-PA and additional PTA/Stenting improves clinical outcome in acute vertebrobasilar occlusion. Stroke 2004; 36: in press
51. Mayer TE, Hamann GF, Brueckmann H. Mechanical extraction of a basilar-artery embolus with the use of flow reversal and a microbasket. N Engl J Med 2002; 347: 769-770
52. Chopko BW, Kerber C, Wong W, et al. Transcatheter snare removal of acute middle cerebral artery thromboembolism: technical case report. Neurosurgery 2000; 46: 1529-1531
53. Berlis A, Lutsep H, Barnwell S, et al. Mechanical thrombolysis in acute ischemic stroke with endovascular photoacoustic recanalization. Stroke 2004; 35: 1112-1116